Apyx Medical Corporation Statistics
Share Statistics
Apyx Medical Corporation has 37.64M shares outstanding. The number of shares has increased by 8.66% in one year.
| Shares Outstanding | 37.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 8.66% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 32.04M |
| Failed to Deliver (FTD) Shares | 982 |
| FTD / Avg. Volume | 1.58% |
Short Selling Information
The latest short interest is 234.86K, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 234.86K |
| Short % of Shares Out | 0.62% |
| Short % of Float | 0.73% |
| Short Ratio (days to cover) | 5.49 |
Valuation Ratios
The PE ratio is -4.85 and the forward PE ratio is -2.63.
| PE Ratio | -4.85 |
| Forward PE | -2.63 |
| PS Ratio | 1.73 |
| Forward PS | 1 |
| PB Ratio | 3.4 |
| P/FCF Ratio | -15.69 |
| PEG Ratio | n/a |
Enterprise Valuation
Apyx Medical Corporation has an Enterprise Value (EV) of 85.56M.
| EV / Earnings | -4.57 |
| EV / Sales | 1.63 |
| EV / EBITDA | -4.72 |
| EV / EBIT | -4.96 |
| EV / FCF | -14.8 |
Financial Position
The company has a current ratio of 5.52, with a Debt / Equity ratio of 1.24.
| Current Ratio | 5.52 |
| Quick Ratio | 4.74 |
| Debt / Equity | 1.24 |
| Total Debt / Capitalization | 55.41 |
| Cash Flow / Debt | -0.16 |
| Interest Coverage | -6.96 |
Financial Efficiency
Return on equity (ROE) is -0.7% and return on capital (ROIC) is -23.37%.
| Return on Equity (ROE) | -0.7% |
| Return on Assets (ROA) | -0.24% |
| Return on Capital (ROIC) | -23.37% |
| Revenue Per Employee | 207.73K |
| Profits Per Employee | -74.26K |
| Employee Count | 252 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.87 |
Taxes
| Income Tax | -2.43M |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by -27.27% in the last 52 weeks. The beta is 1.21, so Apyx Medical Corporation's price volatility has been higher than the market average.
| Beta | 1.21 |
| 52-Week Price Change | -27.27% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 41.35 |
| Average Volume (20 Days) | 62.12K |
Income Statement
In the last 12 months, Apyx Medical Corporation had revenue of 52.35M and earned -18.71M in profits. Earnings per share was -0.54.
| Revenue | 52.35M |
| Gross Profit | 33.76M |
| Operating Income | -17.26M |
| Net Income | -18.71M |
| EBITDA | -18.11M |
| EBIT | -17.26M |
| Earnings Per Share (EPS) | -0.54 |
Balance Sheet
The company has 43.65M in cash and 38.50M in debt, giving a net cash position of 5.15M.
| Cash & Cash Equivalents | 43.65M |
| Total Debt | 38.50M |
| Net Cash | 5.15M |
| Retained Earnings | -54.45M |
| Total Assets | 60.72M |
| Working Capital | 42.60M |
Cash Flow
In the last 12 months, operating cash flow was -5.25M and capital expenditures -533.00K, giving a free cash flow of -5.78M.
| Operating Cash Flow | -5.25M |
| Capital Expenditures | -533.00K |
| Free Cash Flow | -5.78M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 64.49%, with operating and profit margins of -32.97% and -35.75%.
| Gross Margin | 64.49% |
| Operating Margin | -32.97% |
| Pretax Margin | -40.65% |
| Profit Margin | -35.75% |
| EBITDA Margin | -34.6% |
| EBIT Margin | -32.97% |
| FCF Margin | -11.05% |
Dividends & Yields
APYX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -37.5% |
| FCF Yield | -10.67% |
Analyst Forecast
The average price target for APYX is $5, which is 247.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | 247.2% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.46 |
| Piotroski F-Score | 3 |